Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoant...
Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response
About this item
Full title
Author / Creator
Zhao, Yujia , Li, Siyu , Lv, Jianying , Liu, Yonghui , Chen, Yanan , Liu, Yanhua , Chen, Xiaosu , Li, Jia , Qin, Xuan , Wang, Xiaoshuang , Shi, Jie , Shi, Yi and Xiang, Rong
Publisher
Wyoming: Ivyspring International Publisher Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Wyoming: Ivyspring International Publisher Pty Ltd
Subjects
More information
Scope and Contents
Contents
The lack of tumor specific antigens (TSA) and the immune tolerance are two major obstacles for the immunotherapy of cancer. Current immune checkpoint inhibitors (ICIs) show clinical responses in only limited subsets of cancer patients, which, to some extent, depends on the mutation load of tumor cells that may generate neoantigens. Here, we aimed t...
Alternative Titles
Full title
Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8210591
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8210591
Other Identifiers
ISSN
1838-7640
E-ISSN
1838-7640
DOI
10.7150/thno.60211
